NIT
CORT icon

NumerixS Investment Technologies’s Corcept Therapeutics CORT Stock Holding History

NumerixS Investment Technologies’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,100
Closed -$183K – 1048
2019
Q4 		$183K Buy
+15,100
New +$210K 0.04% 513
2019
Q3 		– Sell
-4,100
Closed -$46K – 1048
2019
Q2 		$46K Sell
4,100
-5,500
-57% -$61.3K 0.01% 786
2019
Q1 		$110K Sell
9,600
-3,608
-27% -$44.8K 0.01% 841
2018
Q4 		$172K Buy
13,208
+1,108
+9% +$14.6K 0.06% 393
2018
Q3 		$166K Buy
+12,100
New +$169K 0.03% 646
2018
Q1 		– Sell
-19,200
Closed -$347K – 1078
2017
Q4 		$347K Buy
19,200
+13,400
+231% +$243K 0.08% 290
2017
Q3 		$112K Buy
+5,800
New +$86.5K 0.02% 717

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

NumerixS Investment Technologies's CORT Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Corcept Therapeutics (CORT) in Q1 2020, closing a stake of 15,100 shares — an estimated $183K sold.

NumerixS Investment Technologies first reported a position in CORT in Q3 2017 and held it in 7 quarters. The position peaked at $347K in Q4 2017. 204 funds tracked by Wall St. Rank hold CORT as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Corcept Therapeutics position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 15,100 Corcept Therapeutics shares in Q1 2020, an estimated $183K.
  • NumerixS Investment Technologies first reported a position in Corcept Therapeutics in Q3 2017 and held it in 7 quarters.
  • NumerixS Investment Technologies's Corcept Therapeutics position peaked at $347K in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.